|
1. Lean into ASCs or risk losing revenue, Dr. Brian Cole warns Full story
2. ‘No guarantee it will prevent a monopoly’: Why ASC leaders are skeptical of FTC’s Ascension-AmSurg remedy Full story
3. More ASC leaders are questioning traditional partnership structures. Inside the shift here.
4. ASC parent company TriasMD adds to C-suite Full story
5. Why 70 orthopedic surgeons are betting on independence Full story
6. The gap between revenue cycle and supply chain is quietly eroding margins. Learn more here.
7. Structural changes needed to make value-based care work in spine Full story
8. Dr. Andrew Dossett performs spine surgery on Oklahoma City Thunder player Full story
9. SurGenTec’s Ion-L system earns FDA nod Full story
10. New Jersey system names regional orthopedics chair Full story
11. Pharmacy turnover quietly drains capacity and growth. See what leaders miss here.
12. Dr. Kristy Weber: The most important work in medicine has no RVU Full story
13. The policy shift that has ASC leaders on the edge of their seat Full story
Becker’s Learning Opportunities
14. Nearly $1M per day in financial impact from reducing A/R days. See how here.
15. 1 in 20 people carry a hereditary cancer risk mutation. Most don’t know. Precision medicine can help. Learn more here.
16. The AMA flagged 5 payer workarounds to the NSA. The RCM response, here.
17. Becker’s resources don’t stop here — explore more
webinars
and
whitepapers.
Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by an ASC or provider organization.
|
